Researchmoz added Most up-to-date research on "Increase In Research For The Development Of Asthma Therapeutics In Global Market During The Period 2016 - 2020" to its huge collection of research reports.
Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period.
Technavios analysts forecast the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global asthma therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of brand-name, generic, and off-label drugs used for the prevention and treatment of asthma. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from patent expiries of marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Asthma Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GSK
Merck
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=775675
Other prominent vendors
ALK-Abello
Amgen
Array BioPharma
Asmacure
Astellas Pharma
Atopix Therapeutics
Axikin Pharmaceuticals
Chiesi Farmaceutici
Dynavax Technologies Corp.
Horizon Pharma
Hovione Scientia
Invion
Ivax
Market driver
Huge market potential for mAbs
For a full, detailed list, view our report
Market challenge
Increased preference for CAM
For a full, detailed list, view our report
Market trend
Innovative technologies for drug delivery
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=775675
Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period.
Technavios analysts forecast the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global asthma therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of brand-name, generic, and off-label drugs used for the prevention and treatment of asthma. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from patent expiries of marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Asthma Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GSK
Merck
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=775675
Other prominent vendors
ALK-Abello
Amgen
Array BioPharma
Asmacure
Astellas Pharma
Atopix Therapeutics
Axikin Pharmaceuticals
Chiesi Farmaceutici
Dynavax Technologies Corp.
Horizon Pharma
Hovione Scientia
Invion
Ivax
Market driver
Huge market potential for mAbs
For a full, detailed list, view our report
Market challenge
Increased preference for CAM
For a full, detailed list, view our report
Market trend
Innovative technologies for drug delivery
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=775675
No comments:
Post a Comment